Developing a drug for new diseases cannot only be challenging but also time consuming. From the identification of a druggable target to a compound which can improve a condition it usually takes more than 12 years. Since there is basically an infinite number of possible compounds which can be turned into a drug it is […]

Idiopathic pulmonary fibrosis (IPF) is a chronic and fatal disease lung disease with unknown cause. There are limited treatment options for IPF and investigations into new treatment options is needed. BOLD-100 is a clinical-stage small molecule that is currently being investigated as a treatment option in oncology and viral infections. The pathway that BOLD-100 impacts, […]

Flax seed is of interest as a health food product with high omega-3 fatty acid, protein and fiber content. The seeds naturally contain compound that are anti-nutritive and have a bitter flavor. We have developed a process to safely and cheaply remove these compounds from whole flax seed. We intend to investigate the nutritive qualities, […]

Le but de cette recherche conjointe UQÀM – Anatis Bioprotection est d’améliorer la production de spores virulents de Beauveria Bassiana. Il fait suite au travail de formulation du projet CRSNG Engage 2010. L’amélioration concerne la quantité et la qualité, i.e. survie, virulence et durée de vie…

This project represents the second step in the development of a “Healthy Body Scorecard” which will allow for more comprehensive and holistic approach to measurement and classification of health in children. This particular project will involve a questionnaire study designed to obtain expert opinion on the development of the scorecard as well as a focus […]

Face aux changements globaux, nos infrastructures naturelles, et donc les services qu’elles produisent, sont fortement menacées et le risque de les voir disparaître est de plus en plus inquiétant Ainsi, afin de maintenir – voire augmenter – les services rendus par nos infrastructures naturelles pour le bénéfices des 83% de canadiens vivant en milieux urbains, […]

Genacol Canada Corporation Inc. manufactures a collagen hydrolysate (CH) product, sourced from bovine (Genacol® Original Formula), that has shown promising and positive results in three clinical trials for decreasing joint pain, as well as having a positive effect on articular cartilage. Following digestion, and first pass metabolism, CHs release peptides that have been shown to […]

Eli Health is developing a novel biosensing device to monitor sex hormones in saliva and a mobile application that leverages machine learning to interpret them. The mission of the organization is to enable women to take control of their health across their lives. It will first commercialize the device for fertility and contraception applications. In […]

During the COVID-19 pandemic, it’s become quite apparent that mental health needs to be prioritized. Due to the demands of social isolation, getting adequate mental health support can be difficult. However, the mobile application Rootd provides a low-cost and large-scale solution to this problem, as it can help the average person deal with increased anxiety […]

The objective of this proposal is to develop a new candidate recombinant protein vaccine for the new coronavirus disease 2019 (COVID-19) based on a novel protein delivery and adjuvant technology, iPDT. If successful, this research will advance another COVID-19 vaccine candidate(s) to the pipeline toward clinical use. The causative agent of COVID-19 is SARS coronavirus […]

Age-related macular degeneration (AMD) is a leading cause of blindness that is estimated to affect over 6 million people globally. There are currently no approved treatments for dry AMD, the most common form of the disease. Various lines of inquiry suggest that dysregulation of a part of the innate immune system called complement plays a […]

Given the public health-care system in Canada, many drugs are paid through by the provincial drug plans. Our government makes decisions on which drug to pay for through a process known as health technology assessment whereby manufacturers submit a document that details the clinical, economic and other aspects (e.g. ethical, social) relating to their drug. […]